Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2400057	人胰岛素注射液	human insulin	Injection	Biological Products(3.3)	Supplementary Application	2024-03-01	Wanbang Biopharmaceuticals	view
CYSB2300060	人胰岛素注射液	human insulin	Injection	Biological Products(3.3)	Supplementary Application	2023-03-11	Wanbang Biopharmaceuticals	view
JYSZ2300008	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2023-02-14		view
JYSZ2300006	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2023-02-14		view
JYSZ2300007	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2023-02-14		view
JYSZ2300009	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2023-02-14		view
CYSB2200246	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2022-10-12	Hefei Tianmai BIOTECHNOLOGY Development Co Ltd	view
JYSZ2200022	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	License Renew	2022-06-09		view
JYSZ2200018	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	License Renew	2022-04-25		view
JYSZ2200014	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2022-04-14		view
JYSB2200068	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2022-04-13	Bioton SA	view
CYSB2200088	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	Supplementary Application	2022-03-18	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
JYSZ2200012	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	License Renew	2022-03-11		view
JYSZ2200013	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	License Renew	2022-03-11		view
CYSB2101283	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2021-12-10	Novo Nordisk (China) Pharmaceuticals Co Ltd	view
JYSB2101186	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	Supplementary Application	2021-12-09	Lilly France	view
JYSB2101187	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	Supplementary Application	2021-12-09	Lilly France	view
JYSB2101174	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2021-11-29	Lilly France	view
CYSB2101210	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2021-10-09	Lilly Suzhou Pharmaceutical Co Ltd	view
JYSZ2100527	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2021-08-05		view